Meribank Biotech Co., Ltd (TPEX:4724)

Taiwan · Delayed Price · Currency is TWD

13.85

+0.70 (5.32%)

Apr 20, 2026, 1:10 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Stem Cell Department		228.03M	207.44M	163.09M	163.08M	194.39M
Stem Cell Department Growth		9.93%	27.20%	0.01%	-16.11%	20.78%
Other		50.16M	26.90M	17.04M	-	-
Other Growth		86.43%	57.93%	-	-	-
Management Consulting Department		88.24M	-	-	-	-
Total		366.43M	234.34M	180.12M	163.08M	194.39M
Total Growth		56.37%	30.10%	10.45%	-16.11%	20.78%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan		366.43M	234.34M	180.12M	163.08M	194.39M
Taiwan Growth		56.37%	30.10%	10.45%	-16.11%	20.78%
Total		366.43M	234.34M	180.12M	163.08M	194.39M
Total Growth		56.37%	30.10%	10.45%	-16.11%	20.78%

Source: S&P Global Market Intelligence.